LGND: SEC Form 10-Q filed by Ligand Pharmaceuticals Incorporated
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for LGND
Across the 28 sessions after earlier LGND headlines, the stock closed higher 17 times and lower 11 times, with a median move of 2.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | LGND | SPY |
|---|---|---|---|
| Oct 29, 2026 | Ligand Reports Third Quarter 2026 Financial Results | -0.5% | -0.4% |
| Oct 28, 2026 | Ligand to Participate in November Investor Conferences | +2.3% | +0.3% |
| Oct 23, 2026 | Ligand to Host Investor Day on December 8, 2026 | -1.4% | -0.5% |
| Oct 15, 2026 | Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 | +1.2% | +0.3% |
| Sep 25, 2026 | Barclays initiated coverage on Ligand Pharma with a new price target | +0.8% | +0.5% |
| Sep 24, 2026 | Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million | +0.2% | -0.1% |
Keep researching LGND
- LGND financial statementsRevenue, profit, cash flow and balance sheet from Ligand Pharmaceuticals Incorporated's SEC filings.
- What is Form 10-Q?The quarterly report US public companies file with the SEC for each of the first three fiscal quarters, with unaudited financial statements and MD&A.
- Form 10-K vs 10-QThe difference between a 10-K and a 10-Q: what each report contains, filing deadlines by company size, audited vs reviewed financials, and which sections to read first.
- LGND insider tradesEvery buy and sale reported by Ligand Pharmaceuticals Incorporated officers, directors and large holders.
- LGND earnings historyPast Ligand Pharmaceuticals Incorporated earnings releases, newest first.
Quantisnow market dataNASDAQ
LGND
Ligand Pharmaceuticals Incorporated
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for LGND
Full LGND profile on Quantisnow Follow LGND and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time